Download interactions: TXT MITAB-2.5
| Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
|---|---|---|---|---|---|---|
|
CDK2
Cyclin-dependent kinase 2 |
1 |
5 |
High-throughput |
0.665 | High |
|
|
1433G
14-3-3 protein gamma |
3 |
20 |
High-throughput |
0.662 | High |
|
|
1433B
14-3-3 protein beta/alpha |
3 |
20 |
High-throughput |
0.656 | High |
|
|
K1H1
Keratin, type I cuticular Ha1 |
3 |
10 |
High-throughput |
0.616 | High |
|
|
CD83
CD83 antigen |
2 |
0 |
High-throughput |
0.602 | High |
|
|
MAGAB
Melanoma-associated antigen 11 |
2 |
3 |
High-throughput |
0.590 | High |
|
|
DEFI8
Differentially expressed in FDCP 8 homolog |
2 |
6 |
High-throughput |
0.574 | High |
|
|
FLRT1
Leucine-rich repeat transmembrane protein FLRT1 |
2 |
5 |
High-throughput |
0.574 | High |
|
|
CEP76
Centrosomal protein of 76 kDa |
1 |
2 |
High-throughput |
0.573 | High |
|
|
CHIO
Beta-chimaerin |
2 |
11 |
High-throughput |
0.571 | High |
|
|
RHGBB
Inactive Rho GTPase-activating protein 11B |
2 |
15 |
High-throughput |
0.571 | High |
|
|
EFNB2
Ephrin-B2 |
2 |
6 |
High-throughput |
0.558 | High |
|
|
RAP1A
Ras-related protein Rap-1A |
1 |
20 |
Small-scale |
0.553 | High |
|
|
LATS2
Serine/threonine-protein kinase LATS2 |
1 |
20 |
High-throughput |
0.553 | High |
|
|
C5AR1
C5a anaphylatoxin chemotactic receptor 1 |
1 |
16 |
High-throughput |
0.536 | High |
|
|
1433E
14-3-3 protein epsilon |
1 |
8 |
High-throughput |
0.536 | High |
|
|
GRB2
Growth factor receptor-bound protein 2 |
1 |
16 |
High-throughput |
0.536 | High |
|
|
1433Z
14-3-3 protein zeta/delta |
1 |
20 |
High-throughput |
0.536 | High |
|
|
EFNB1
Ephrin-B1 |
1 |
6 |
High-throughput |
0.536 | High |
|
|
NEMO
NF-kappa-B essential modulator |
1 |
11 |
High-throughput |
0.536 | High |
|
|
MR1L1
MORF4 family-associated protein 1-like 1 |
1 |
1 |
High-throughput |
0.523 | High |
|
|
GPR17
Uracil nucleotide/cysteinyl leukotriene receptor |
1 |
20 |
High-throughput |
0.489 | High |
|
|
UBP7
Ubiquitin carboxyl-terminal hydrolase 7 |
1 |
7 |
High-throughput |
0.481 | High |
|
|
GBB1
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 |
1 |
5 |
Small-scale |
0.479 | High |
|
|
CAV1
Caveolin-1 |
1 |
6 |
High-throughput |
0.479 | High |
|
|
1433F
14-3-3 protein eta |
1 |
20 |
High-throughput |
0.479 | High |
|
|
CCNH
Cyclin-H |
1 |
2 |
High-throughput |
0.470 | High |
|
|
MED19
Mediator of RNA polymerase II transcription subunit 19 |
1 |
1 |
High-throughput |
0.439 | High |
|
|
FGFR3
Fibroblast growth factor receptor 3 |
1 |
20 |
High-throughput |
0.439 | High |
|
|
ASCC2
Activating signal cointegrator 1 complex subunit 2 |
1 |
1 |
High-throughput |
0.439 | High |
|
|
EGLN3
Prolyl hydroxylase EGLN3 |
1 |
3 |
High-throughput |
0.437 | High |
|
|
SMYD2
N-lysine methyltransferase SMYD2 |
1 |
1 |
High-throughput |
0.437 | High |
|
|
HECW2
E3 ubiquitin-protein ligase HECW2 |
1 |
11 |
High-throughput |
0.437 | High |
|
|
SIGL1
SIGLEC family-like protein 1 |
2 |
0 |
High-throughput |
0.328 | High |
|
|
PNKD
Probable hydrolase PNKD |
2 |
0 |
High-throughput |
0.318 | High |
|
|
APOC1
Apolipoprotein C-I |
2 |
0 |
High-throughput |
0.316 | High |
|
|
GATA1
Erythroid transcription factor |
1 |
0 |
High-throughput |
0.299 | High |
|
|
SFI1
Protein SFI1 homolog |
1 |
0 |
High-throughput |
0.282 | High |
|
|
RHXF2
Rhox homeobox family member 2 |
1 |
0 |
High-throughput |
0.282 | High |
|
|
TEX19
Testis-expressed protein 19 |
1 |
0 |
High-throughput |
0.279 | Low |
|
|
HCST
Hematopoietic cell signal transducer |
1 |
0 |
High-throughput |
0.279 | Low |
|
|
RA51D
DNA repair protein RAD51 homolog 4 |
1 |
0 |
High-throughput |
0.269 | Low |
|
|
PUR9
Bifunctional purine biosynthesis protein ATIC |
1 |
0 |
High-throughput |
0.269 | Low |
|
|
DEGS1
Sphingolipid delta(4)-desaturase DES1 |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
CFLAR
CASP8 and FADD-like apoptosis regulator |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
RPA49
DNA-directed RNA polymerase I subunit RPA49 |
1 |
0 |
High-throughput |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024
